156 related articles for article (PubMed ID: 24650357)
1. Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.
Hammoudeh DI; Daté M; Yun MK; Zhang W; Boyd VA; Viacava Follis A; Griffith E; Lee RE; Bashford D; White SW
ACS Chem Biol; 2014 Jun; 9(6):1294-302. PubMed ID: 24650357
[TBL] [Abstract][Full Text] [Related]
2. Catalysis and sulfa drug resistance in dihydropteroate synthase.
Yun MK; Wu Y; Li Z; Zhao Y; Waddell MB; Ferreira AM; Lee RE; Bashford D; White SW
Science; 2012 Mar; 335(6072):1110-4. PubMed ID: 22383850
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.
Babaoglu K; Qi J; Lee RE; White SW
Structure; 2004 Sep; 12(9):1705-17. PubMed ID: 15341734
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
6. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
7. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
Valderas MW; Andi B; Barrow WW; Cook PF
Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
[TBL] [Abstract][Full Text] [Related]
8. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
Levy C; Minnis D; Derrick JP
Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
[TBL] [Abstract][Full Text] [Related]
9. Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.
Zhao Y; Hammoudeh D; Lin W; Das S; Yun MK; Li Z; Griffith E; Chen T; White SW; Lee RE
Bioconjug Chem; 2011 Oct; 22(10):2110-7. PubMed ID: 21916405
[TBL] [Abstract][Full Text] [Related]
10. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
[TBL] [Abstract][Full Text] [Related]
11. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
Giordanetto F; Fowler PW; Saqi M; Coveney PV
Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
[TBL] [Abstract][Full Text] [Related]
12. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
13. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
14. Insights into the drug resistance induced by the BaDHPS mutations: molecular dynamic simulations and MM/GBSA studies.
Chu WT; Zhang JL; Zheng QC; Chen L; Xue Q; Zhang HX
J Biomol Struct Dyn; 2013 Oct; 31(10):1127-36. PubMed ID: 23030549
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.
Dennis ML; Chhabra S; Wang ZC; Debono A; Dolezal O; Newman J; Pitcher NP; Rahmani R; Cleary B; Barlow N; Hattarki M; Graham B; Peat TS; Baell JB; Swarbrick JD
J Med Chem; 2014 Nov; 57(22):9612-26. PubMed ID: 25357262
[TBL] [Abstract][Full Text] [Related]
16. Class-Specific Monoclonal Antibodies and Dihydropteroate Synthase in Bioassays Used for the Detection of Sulfonamides: Structural Insights into Recognition Diversity.
Li C; Liang X; Wen K; Li Y; Zhang X; Ma M; Yu X; Yu W; Shen J; Wang Z
Anal Chem; 2019 Feb; 91(3):2392-2400. PubMed ID: 30580515
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.
Pemble CW; Mehta PK; Mehra S; Li Z; Nourse A; Lee RE; White SW
PLoS One; 2010 Nov; 5(11):e14165. PubMed ID: 21152407
[TBL] [Abstract][Full Text] [Related]
18. Exploring the catalytic mechanism of dihydropteroate synthase: elucidating the differences between the substrate and inhibitor.
Chotpatiwetchkul W; Boonyarattanakalin K; Gleeson D; Gleeson MP
Org Biomol Chem; 2017 Jul; 15(26):5593-5601. PubMed ID: 28639657
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity.
Zhao Y; Hammoudeh D; Yun MK; Qi J; White SW; Lee RE
ChemMedChem; 2012 May; 7(5):861-70. PubMed ID: 22416048
[TBL] [Abstract][Full Text] [Related]
20. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
